Cyclacel Pharmaceuticals, Inc. CYCC
Set alert
6.37 0.00 0.00%
At close · Sep 11
6.10 Day range 6.96
52-week range unavailable
- Open
- 6.76
- Prev close
- 6.37
- Mkt cap
- 10.61M
- Vol
- 219.91K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.10
- High
- 6.96
- Forward P/E
- -0.16
- Beta
- 0.56
- Short ratio
- 0.03
- Inst. own
- 18.03%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.5528
- 200-d avg
- 1.41
- 1y target
- 1.00
6M chart
Events in this range
- Aug 14, 2024Earnings: -0.72; estimate -0.83; surprise 13.25%
- Nov 12, 2024Earnings: -0.18; estimate -0.54; surprise 66.67%
Signals (23)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 21, 2024 | 1 year ago |
| RSI: Oversold | Nov 5, 2024 | 1 year ago |
| MACD: Sell Signal | Oct 28, 2024 | 2 years ago |
| SMA: Bearish | Oct 24, 2024 | 2 years ago |
| SMA: Bearish | Oct 23, 2024 | 2 years ago |
| SMA: Bullish | Oct 22, 2024 | 2 years ago |
| RSI: Overbought | Oct 21, 2024 | 2 years ago |
| SMA: Bullish | Oct 18, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 16, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 9, 2024 | 2 years ago |
| RSI: Oversold | Oct 9, 2024 | 2 years ago |
| RSI: Oversold | Oct 4, 2024 | 2 years ago |
| RSI: Oversold | Sep 20, 2024 | 2 years ago |
| RSI: Oversold | Sep 13, 2024 | 2 years ago |
| RSI: Oversold | Sep 10, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 9, 2024 | 2 years ago |
| RSI: Oversold | Aug 27, 2024 | 2 years ago |
| RSI: Oversold | Aug 19, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 5, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 10, 2024 | 2 years ago |
Newest 20 of 23.
Analyst view
Price target (mean) 1.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.29 | -0.29 – -0.29 | -6.23 | +95.3% | 10.00K | -67.7% | 1 |
| Next quarter | -0.29 | -0.29 – -0.29 | -2.27 | +87.2% | 25.00K | -13.8% | 1 |
| Current year | -1.95 | -1.95 – -1.95 | -26.75 | +92.7% | 53.00K | -87.4% | 1 |
| Next year | -1.18 | -1.18 – -1.18 | -1.95 | +39.5% | 100.00K | +88.7% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 3, 2024 | Roth MKM | Maintained | Buy | Buy |
| Dec 19, 2023 | Brookline Capital | Downgrade | Buy | Hold |
| Dec 19, 2023 | Roth MKM | Maintained | Buy | Buy |